Bank Pictet & Cie Europe AG Has $87.38 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Pictet & Cie Europe AG boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 196,433 shares of the medical equipment provider’s stock after buying an additional 843 shares during the quarter. Intuitive Surgical makes up about 2.1% of Bank Pictet & Cie Europe AG’s investment portfolio, making the stock its 10th largest holding. Bank Pictet & Cie Europe AG’s holdings in Intuitive Surgical were worth $87,383,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Creekmur Asset Management LLC grew its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the period. Delos Wealth Advisors LLC lifted its holdings in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares in the last quarter. LRI Investments LLC purchased a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. Able Wealth Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, MeadowBrook Investment Advisors LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG traded down $3.88 during midday trading on Friday, hitting $486.55. The stock had a trading volume of 1,155,222 shares, compared to its average volume of 1,536,912. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $493.97. The firm has a market cap of $172.58 billion, a PE ratio of 87.82, a price-to-earnings-growth ratio of 4.97 and a beta of 1.39. The stock’s 50 day moving average is $449.52 and its 200 day moving average is $411.24.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the prior year, the firm posted $1.18 earnings per share. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have weighed in on ISRG. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a report on Friday, July 19th. The Goldman Sachs Group began coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They set a “buy” rating and a $500.00 price target on the stock. Morgan Stanley boosted their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. BTIG Research upped their target price on shares of Intuitive Surgical from $451.00 to $459.00 and gave the stock a “buy” rating in a research report on Monday, July 15th. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $444.70.

Insider Activity

In other news, EVP Robert Desantis sold 584 shares of the stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $404.41, for a total value of $236,175.44. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,226,681.46. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $411.00, for a total value of $575,400.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 584 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $404.41, for a total transaction of $236,175.44. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,226,681.46. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,309 shares of company stock valued at $6,642,470. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.